Literature DB >> 30104449

Preparation and in vitro evaluation of novel cross-linked chondroitin sulphate nanoparticles by aluminium ions for encapsulation of green tea flavonoids.

Jaleh Varshosaz1, Hajar Asefi2, Batool Hashemi-Beni3, Solmaz Ghaffari2, Ali Davoudi4.   

Abstract

Chondroitin sulphate is a sulphated glycosaminoglycan biopolymer composed over 100 individual sugars. Chondroitin sulphate nanoparticles (NPs) loaded with catechin were prepared by an ionic gelation method using AlCl3 and optimised for polymer and cross-linking agent concentration, curing time and stirring speed. Zeta potential, particle size, loading efficiency, and release efficiency over 24 h (RE24%) were evaluated. The surface morphology of NPs was investigated by scanning electron microscopy and their thermal behaviour by differential scanning calorimetric. Antioxidant effect of NPs was determined by chelating activity of iron ions. The cell viability of mesenchymal stem cells was determined by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide assay and the calcification of osteoblasts was studied by Alizarin red staining. The optimised NPs showed particle size of 176 nm, zeta potential of -20.8 mV, loading efficiency of 93.3% and RE24% of 80.6%. The chatechin loaded chondroitin sulphate NPs showed 70-fold more antioxidant activity, 3-fold proliferation effect and higher calcium precipitation in osteoblasts than free catechin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30104449      PMCID: PMC8676605          DOI: 10.1049/iet-nbt.2017.0298

Source DB:  PubMed          Journal:  IET Nanobiotechnol        ISSN: 1751-8741            Impact factor:   1.847


  21 in total

1.  Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.

Authors:  Pan Jin; Huayu Wu; Guojie Xu; Li Zheng; Jinmin Zhao
Journal:  Cell Tissue Res       Date:  2014-03-29       Impact factor: 5.249

2.  Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.

Authors:  Joana F Fangueiro; Ana C Calpena; Beatriz Clares; Tatiana Andreani; Maria A Egea; Francisco J Veiga; Maria L Garcia; Amélia M Silva; Eliana B Souto
Journal:  Int J Pharm       Date:  2016-02-24       Impact factor: 5.875

3.  Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.

Authors:  Admire Dube; Joseph A Nicolazzo; Ian Larson
Journal:  Eur J Pharm Sci       Date:  2010-06-19       Impact factor: 4.384

4.  Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.

Authors:  Zhiyong Hong; Yongquan Xu; Jun-Feng Yin; Jianchang Jin; Yongwen Jiang; Qizhen Du
Journal:  J Agric Food Chem       Date:  2014-12-17       Impact factor: 5.279

Review 5.  Green tea and bone metabolism.

Authors:  Chwan-Li Shen; James K Yeh; Jay J Cao; Jia-Sheng Wang
Journal:  Nutr Res       Date:  2009-07       Impact factor: 3.315

Review 6.  Polysaccharides-based nanoparticles as drug delivery systems.

Authors:  Zonghua Liu; Yanpeng Jiao; Yifei Wang; Changren Zhou; Ziyong Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-09-17       Impact factor: 15.470

7.  Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.

Authors:  Jong-Ho Lee; Hexiu Jin; Hye-Eun Shim; Ha-Neui Kim; Hyunil Ha; Zang Hee Lee
Journal:  Mol Pharmacol       Date:  2009-10-14       Impact factor: 4.436

Review 8.  Zeta potential of microfluidic substrates: 2. Data for polymers.

Authors:  Brian J Kirby; Ernest F Hasselbrink
Journal:  Electrophoresis       Date:  2004-01       Impact factor: 3.535

9.  Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI.

Authors:  Lukas Martin Wildi; Jean-Pierre Raynauld; Johanne Martel-Pelletier; André Beaulieu; Louis Bessette; Frédéric Morin; François Abram; Marc Dorais; Jean-Pierre Pelletier
Journal:  Ann Rheum Dis       Date:  2011-03-01       Impact factor: 19.103

10.  Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study.

Authors:  Seyedeh Sara Shafiei; Mehran Solati-Hashjin; Ali Samadikuchaksaraei; Reza Kalantarinejad; Mitra Asadi-Eydivand; Noor Azuan Abu Osman
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.